Stock Screener App

Frei -

Installieren

2.17

7.23% -0.18

after-market

Handel nachbörslich: 2.17

Galectin Therapeutics Inc (GALT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Galectin Therapeutics Inc-Aktie (GALT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	9.23% 4.198	4.625	7.897	12.43	9.066
Operating Income/Loss	9.23% -4.198	-4.625	-7.897	-12.43	-9.066
Nonoperating Income/Loss	37.64% -3.986	-2.896	-1.734	0.461	-2.154
Income/Loss From Continuing Operations Before Tax	8.82% -8.184	-7.521	-9.631	-11.97	-11.22
Income/Loss From Continuing Operations After Tax	8.82% -8.184	-7.521	-9.631	-11.97	-11.22
Net Income/Loss	8.82% -8.184	-7.521	-9.631	-11.97	-11.22
Preferred Stock Dividends And Other Adjustments	38.10% 0.039	0.063	-0.026	0.063	0.018
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.19% 64.20	63.45	63.20	0.146	62.28
Diluted Average Shares	1.19% 64.20	63.45	63.20	0.146	62.28
Basic Earnings Per Share	8.33% -0.13	-0.12	-0.15	-0.19	-0.18
Diluted Earnings Per Share	8.33% -0.13	-0.12	-0.15	-0.19	-0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	38.10% 0.039	0.063	-0.026	0.063	0.018

ROIV

$29.29

0.25%

BNTX

$89.55

2.71%

RPRX

$52.86

0.80%

INSM

$109.14

5.52%

ONC

$293.27

3.55%

RVMD

$145.66

2.52%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters